Sustained antibody responses depend on CD28 function in bone marrow–resident plasma cells

CD28 signaling is essential for maintenance of long-term antigen-specific antibody production and for persistence of plasma cells in the bone marrow of mice.

[1]  C. Berek,et al.  Eosinophils are required for the maintenance of plasma cells in the bone marrow , 2011, Nature Immunology.

[2]  F. Hermann,et al.  Basophils Support the Survival of Plasma Cells in Mice , 2010, The Journal of Immunology.

[3]  I. Maclennan,et al.  Megakaryocytes constitute a functional component of a plasma cell niche in the bone marrow. , 2010, Blood.

[4]  M. Slifka,et al.  Mechanisms that determine plasma cell lifespan and the duration of humoral immunity , 2010, Immunological reviews.

[5]  Bart Barlogie,et al.  The sumoylation pathway is dysregulated in multiple myeloma and is associated with adverse patient outcome. , 2010, Blood.

[6]  Bali Pulendran,et al.  Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology , 2009, Nature Reviews Immunology.

[7]  S. Tangye,et al.  Memory B cells: Effectors of long‐lived immune responses , 2009, European journal of immunology.

[8]  L. Otten,et al.  CD93 is required for maintenance of antibody secretion and persistence of plasma cells in the bone marrow niche , 2009, Proceedings of the National Academy of Sciences.

[9]  Steffen Jung,et al.  Perivascular clusters of dendritic cells provide critical survival signals to B cells in bone marrow niches , 2008, Nature Immunology.

[10]  K. Calame,et al.  Regulation and functions of Blimp-1 in T and B lymphocytes. , 2008, Annual review of immunology.

[11]  R. Geha,et al.  Cutting Edge: The Dependence of Plasma Cells and Independence of Memory B Cells on BAFF and APRIL1 , 2008, The Journal of Immunology.

[12]  Mark J. Shlomchik,et al.  Maintenance of the plasma cell pool is independent of memory B cells , 2008, Proceedings of the National Academy of Sciences.

[13]  L. Garrett-Sinha,et al.  Ets-1 Regulates Plasma Cell Differentiation by Interfering with the Activity of the Transcription Factor Blimp-1* , 2008, Journal of Biological Chemistry.

[14]  Thomas F. Tedder,et al.  Maintenance of Long-Lived Plasma Cells and Serological Memory Despite Mature and Memory B Cell Depletion during CD20 Immunotherapy in Mice1 , 2008, The Journal of Immunology.

[15]  Nichole E Carlson,et al.  Duration of humoral immunity to common viral and vaccine antigens. , 2007, The New England journal of medicine.

[16]  Kenneth G. C. Smith,et al.  FcγRIIb controls bone marrow plasma cell persistence and apoptosis , 2007, Nature Immunology.

[17]  J. Clements,et al.  The Src Homology 2 Domain-Containing Leukocyte Protein of 76-kDa Adaptor Links Integrin Ligation with p44/42 MAPK Phosphorylation and Podosome Distribution in Murine Dendritic Cells1 , 2006, The Journal of Immunology.

[18]  David R Williams,et al.  Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis. , 2006, Blood.

[19]  Kenneth G. C. Smith,et al.  Competence and competition: the challenge of becoming a long-lived plasma cell , 2006, Nature Reviews Immunology.

[20]  Lindzy D. Friend,et al.  A dose-dependent requirement for the proline motif of CD28 in cellular and humoral immunity revealed by a targeted knockin mutant , 2006, The Journal of experimental medicine.

[21]  S. Jagannath,et al.  Enhancement of clonogenicity of human multiple myeloma by dendritic cells , 2006, The Journal of experimental medicine.

[22]  K. Calame,et al.  Transcriptional repressor Blimp-1 regulates T cell homeostasis and function , 2006, Nature Immunology.

[23]  Andreas Radbruch,et al.  Long-lived plasma cells in immunity and immunopathology. , 2006, Immunology letters.

[24]  M. Busslinger,et al.  Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells. , 2006, Immunity.

[25]  K. Calame,et al.  Blimp-1 is required for maintenance of long-lived plasma cells in the bone marrow , 2005, The Journal of experimental medicine.

[26]  B. Levine,et al.  CD28-mediated regulation of multiple myeloma cell proliferation and survival. , 2005, Blood.

[27]  Lingyun Zhu,et al.  Regulation of IκBα expression involves both NF-κB and the MAP kinase signaling pathways , 2005, Journal of Inflammation.

[28]  J. Licinio,et al.  Peripheral is Central to the question , 2005, Molecular Psychiatry.

[29]  K. Calame,et al.  Regulation of plasma-cell development , 2005, Nature Reviews Immunology.

[30]  Ciriana Orabona,et al.  CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86 , 2004, Nature Immunology.

[31]  Jhagvaral Hasbold,et al.  Plasma Cell Ontogeny Defined by Quantitative Changes in Blimp-1 Expression , 2004, The Journal of experimental medicine.

[32]  Takashi Nagasawa,et al.  Cellular niches controlling B lymphocyte behavior within bone marrow during development. , 2004, Immunity.

[33]  K. Georgopoulos,et al.  Aiolos Is Required for the Generation of High Affinity Bone Marrow Plasma Cells Responsible for Long-Term Immunity , 2004, The Journal of experimental medicine.

[34]  K. Calame,et al.  Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells. , 2003, Immunity.

[35]  Liming Yang,et al.  Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. , 2002, Immunity.

[36]  C. Thompson,et al.  The CD28 signaling pathway regulates glucose metabolism. , 2002, Immunity.

[37]  Andreas Radbruch,et al.  Plasma cells for a lifetime? , 2002, European journal of immunology.

[38]  G. Freeman,et al.  The B7–CD28 superfamily , 2002, Nature Reviews Immunology.

[39]  M. Mollenauer,et al.  Endogenous CD28 expressed on myeloma cells up-regulates interleukin-8 production: implications for multiple myeloma progression. , 2001, Blood.

[40]  A. Lichtenstein,et al.  The phosphatidylinositol 3-kinase/AKT kinase pathway in multiple myeloma plasma cells: roles in cytokine-dependent survival and proliferative responses. , 2000, Cancer research.

[41]  N. Tuaillon.  Repertoire analysis in human immunoglobulin heavy chain minilocus transgenic, muMT/muMT mice. , 2000, Molecular immunology.

[42]  A. Órfão,et al.  High‐sensitive immunophenotyping and DNA ploidy studies for the investigation of minimal residual disease in multiple myeloma , 1999, British journal of haematology.

[43]  Martine,et al.  CD28, a marker associated with tumoral expansion in multiple myeloma. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[44]  R. Ahmed,et al.  Humoral immunity due to long-lived plasma cells. , 1998, Immunity.

[45]  Andreas Radbruch,et al.  Lifetime of plasma cells in the bone marrow , 1997, Nature.

[46]  A. Weiss,et al.  CD28 mediates transcriptional upregulation of the interleukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites , 1997, Molecular and cellular biology.

[47]  G. Pinkus,et al.  The role of follicular and interdigitating dendritic cells in HIV-related lymphoid hyperplasia: localization of fascin. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[48]  C. Thompson,et al.  CD28 is required for germinal center formation. , 1996, Journal of immunology.

[49]  C. Thompson,et al.  CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. , 1995, Immunity.

[50]  A. Weiss,et al.  The cytoplasmic domain of CD28 is both necessary and sufficient for costimulation of interleukin-2 secretion and association with phosphatidylinositol 3'-kinase , 1994, Molecular and cellular biology.

[51]  K P Lee,et al.  Differential T cell costimulatory requirements in CD28-deficient mice. , 1993, Science.

[52]  C. Thompson,et al.  CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[53]  H. Asaoku,et al.  Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas , 1988, Nature.

[54]  L. Moretta,et al.  Tp44 molecules involved in antigen-independent T cell activation are expressed on human plasma cells. , 1987, Journal of immunology.

[55]  P. Witte,et al.  Plasma cell purification from murine bone marrow using a two-step isolation approach. , 2008, Journal of immunological methods.

[56]  Kenneth G. C. Smith,et al.  FcgammaRIIb controls bone marrow plasma cell persistence and apoptosis. , 2007, Nature immunology.

[57]  B. Bogen.  A mouse model for immunotherapy of myeloma. , 2002, The hematology journal : the official journal of the European Haematology Association.